Ser1027
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.4
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser1027  -  REST (human)

Site Information
SDNMsEGsDDsGLHG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 138107500

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
prostate cancer ( 1 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on REST:
protein degradation ( 1 ) , ubiquitination ( 1 )

References 

1

Chen R, Li Y, Buttyan R, Dong X (2017) Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells. Oncotarget 8, 84863-84876
29156689   Curated Info